References
Engelhard M, Stuschke M. Report on workshop: UICC workshop “Therapy of NHL in early stages.” Part 1: Follicular lymphoma. Ann Hematol. 2001;80(suppl 3):B13-B15.
Wilder RB, Jones D,Tucker SL, et al. Long-term results with radiotherapy for stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys. 2001;51:1219–1227.
Vaughan-Hudson B, Vaughan-Hudson G, MacLennan KA, Anderson L, Linch DC. Clinical stage 1 non-Hodgkin’s lymphoma: long-term follow-up of patients treated by the British National Lym-phoma Investigation with radiotherapy alone as initial therapy. Br J Cancer. 1994;69:1088–1093.
MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low grade follicular lymphoma? Results of long-term follow-up of patients treated at Stanford University. J Clin Oncol. 1996;14:1282–1290.
Jaffe ES, Harris NL, Stein H,Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin’s Lymphoma Pathologic Classification Project. Cancer. 1982;49:2112–2135.
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res. 1971;31:1860–1861.
A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987–994.
Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lym-phomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244–1253.
Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–1265.
Hainsworth JD, Litchy S, Burris HA {jr3rd}, et al. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin’s lymphoma. J Clin Oncol. 2002;20:4261–4267.
Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin’s lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol. 2004;22:4711–4716.
Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ. Adjuvant cyclophosphamide, doxorubicin, vincristine, and pred-nisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer. 1993;71:2342–2350.
Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin’s lymphoma: long-term follow-up of no initial therapy. J Clin Oncol. 2004;22:1454–1459.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tomita, N., Kodama, F., Motohashi, K. et al. Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma. Int J Hematol 83, 370–372 (2006). https://doi.org/10.1532/IJH97.06041
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.06041